213 related articles for article (PubMed ID: 535182)
1. The association of cryoglobulinaemia with nodules, vasculitis and fibrosing alveolitis in rheumatoid arthritis and their relationship to serum C1q binding activity and rheumatoid factor.
Erhardt CC; Mumford P; Maini RN
Clin Exp Immunol; 1979 Dec; 38(3):405-13. PubMed ID: 535182
[TBL] [Abstract][Full Text] [Related]
2. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
3. Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis.
Weisman M; Zvaifler N
J Clin Invest; 1975 Sep; 56(3):725-39. PubMed ID: 169295
[TBL] [Abstract][Full Text] [Related]
4. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.
Zubler RH; Nydegger U; Perrin LH; Fehr K; McCormick J; Lambert PH; Miescher PA
J Clin Invest; 1976 May; 57(5):1308-19. PubMed ID: 944196
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes in patients with cryptogenic fibrosing alveolitis.
Haslam PL; Thompson B; Mohammed I; Townsend PJ; Hodson ME; Holborow EJ; Turner-Warwick M
Clin Exp Immunol; 1979 Sep; 37(3):381-90. PubMed ID: 315841
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes in cutaneous vasculitis. Detection with C1q and monoclonal rheumatoid factor.
Mackel SE; Tappeiner G; Brumfield H; Jordan RE
J Clin Invest; 1979 Dec; 64(6):1652-60. PubMed ID: 500831
[TBL] [Abstract][Full Text] [Related]
8. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of Clq binding activity by IgM rheumatoid factor.
Zilberfarb JL; Andrews BS; Young AC; Davis JS
J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes and rheumatoid arthritis.
Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to extractable nuclear antigens in rheumatoid arthritis: relationship to vasculitis and circulating immune complexes.
Venables PJ; Erhardt CC; Maini RN
Clin Exp Immunol; 1980 Jan; 39(1):146-53. PubMed ID: 6771070
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
[TBL] [Abstract][Full Text] [Related]
13. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
14. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
[TBL] [Abstract][Full Text] [Related]
15. Granulomatous cutaneous rheumatoid vasculitis.
Callen JP; Ahrens EM
J Rheumatol; 1988 Jun; 15(6):1005-8. PubMed ID: 3418621
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
Naama JK; Mitchell WS; Whaley K
Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
[TBL] [Abstract][Full Text] [Related]
17. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
18. [Serum immune complexes in rheumatoid arthritis (a study of 100 cases). Comparison of the results obtained by four different detection techniques].
Piton JL; Alibeu C; Renversez JC; Chenais F; Tournoud A; Dodelier C; Phelip X; Cabanel G
Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):9-18. PubMed ID: 6342115
[TBL] [Abstract][Full Text] [Related]
19. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.
Mallya RK; Vergani D; Tee DE; Bevis L; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
Clin Exp Immunol; 1982 Jun; 48(3):747-53. PubMed ID: 6981476
[TBL] [Abstract][Full Text] [Related]
20. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis.
Quismorio FP; Beardmore T; Kaufman RL; Mongan ES
Clin Exp Immunol; 1983 May; 52(2):333-40. PubMed ID: 6602676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
